Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Harald Hampel, Yan Hu, Jeffrey L. Cummings, et al.
Neuron (2023) Vol. 111, Iss. 18, pp. 2781-2799
Open Access | Times Cited: 116
Tau-targeting therapies for Alzheimer disease: current status and future directions
Erin E. Congdon, Changyi Ji, Amber M. Tetlow, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 715-736
Closed Access | Times Cited: 113
Alternative splicing in neurodegenerative disease and the promise of RNA therapies
David Nikom, Sika Zheng
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 8, pp. 457-473
Closed Access | Times Cited: 77
Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
Mohammed Alsubaie, Suhuai Luo, Kamran Shaukat
Machine Learning and Knowledge Extraction (2024) Vol. 6, Iss. 1, pp. 464-505
Open Access | Times Cited: 25
Brain clearance of protein aggregates: a close-up on astrocytes
Veronica Giusti, G Kaur, Elena Giusto, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 19
The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
Sarah Buchholz, Hans Zempel
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3606-3628
Open Access | Times Cited: 19
Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
Zhao Sun, Ji‐Sun Kwon, Yudong Ren, et al.
Science (2024) Vol. 385, Iss. 6708
Closed Access | Times Cited: 15
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies
Elisa Uliassi, María Laura Bolognesi, Andrea Milelli
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 654-672
Closed Access | Times Cited: 2
Tau Isoforms: Gaining Insight into MAPT Alternative Splicing
Andrea Corsi, Cristina Bombieri, Maria Teresa Valenti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15383-15383
Open Access | Times Cited: 48
Role of aberrant phase separation in pathological protein aggregation
Pijush Chakraborty, Markus Zweckstetter
Current Opinion in Structural Biology (2023) Vol. 82, pp. 102678-102678
Closed Access | Times Cited: 36
Microglial REV-ERBα regulates inflammation and lipid droplet formation to drive tauopathy in male mice
Jiyeon Lee, Julie Dimitry, Jong Hee Song, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Young‐onset dementia diagnosis, management and care: a narrative review
Samantha M. Loi, Monica Cations, Dennis Velakoulis
The Medical Journal of Australia (2023) Vol. 218, Iss. 4, pp. 182-189
Open Access | Times Cited: 31
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 916-916
Open Access | Times Cited: 22
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 22
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
Wen Li, Jiayi Li
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Tau protein profiling in tauopathies: a human brain study
Juan Lantero Rodrı́guez, Elena Camporesi, Laia Montoliu‐Gaya, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10
The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and AppNL−F/NL−F mice
Cristina Nuñez‐Diaz, Emelie Andersson, Nina Schultz, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau
Zhouquan Jiang, Jing Wang, Yongpeng Qin, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Nuclear pore dysfunction and disease: a complex opportunity
Charlotte M. Fare, Jeffrey D. Rothstein
Nucleus (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology
Sania Bashir, Ayesha Aiman, Mohammad Shahid, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102276-102276
Closed Access | Times Cited: 9
Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies
Anton Lindberg, Emily Murrell, Junchao Tong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Current Progress and Future Directions in Non-Alzheimer’s Disease Tau PET Tracers
Hendris Wongso, Ryuichi Harada, Shozo Furumoto
ACS Chemical Neuroscience (2025) Vol. 16, Iss. 2, pp. 111-127
Closed Access | Times Cited: 1
Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review
Radhakrishna Reddi Sree, Manjunath Kalyan, Nikhilesh Anand, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 5148-5171
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top